These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 1833454)
1. Identification of 5'-regions affecting the expression of the human CR2 gene. Yang LM; Behrens M; Weis JJ J Immunol; 1991 Oct; 147(7):2404-10. PubMed ID: 1833454 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. Rayhel EJ; Dehoff MH; Holers VM J Immunol; 1991 Mar; 146(6):2021-6. PubMed ID: 1706386 [TBL] [Abstract][Full Text] [Related]
3. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene. Christensen SM; Martin BK; Tan SS; Weis JH J Immunol; 1992 Jun; 148(11):3610-7. PubMed ID: 1534100 [TBL] [Abstract][Full Text] [Related]
4. Loss of human CR1- and murine Crry-like exons in human CR2 transcripts due to CR2 gene mutations. Holguin MH; Kurtz CB; Parker CJ; Weis JJ; Weis JH J Immunol; 1990 Sep; 145(6):1776-81. PubMed ID: 2144008 [TBL] [Abstract][Full Text] [Related]
5. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene. Makar KW; Pham CT; Dehoff MH; O'Connor SM; Jacobi SM; Holers VM J Immunol; 1998 Feb; 160(3):1268-78. PubMed ID: 9570543 [TBL] [Abstract][Full Text] [Related]
6. Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry. Kurtz CB; Paul MS; Aegerter M; Weis JJ; Weis JH J Immunol; 1989 Sep; 143(6):2058-67. PubMed ID: 2528587 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the promoter region of the membrane cofactor protein (CD46) gene of the human complement system and comparison to a membrane cofactor protein-like genetic element. Cui W; Hourcade D; Post T; Greenlund AC; Atkinson JP; Kumar V J Immunol; 1993 Oct; 151(8):4137-46. PubMed ID: 7691939 [TBL] [Abstract][Full Text] [Related]
8. Identification of 5'-flanking regions affecting the expression of the human decay accelerating factor gene and their role in tissue-specific expression. Thomas DJ; Lublin DM J Immunol; 1993 Jan; 150(1):151-60. PubMed ID: 7678027 [TBL] [Abstract][Full Text] [Related]
9. Genomic structure and chromosomal mapping of the human CD22 gene. Wilson GL; Najfeld V; Kozlow E; Menniger J; Ward D; Kehrl JH J Immunol; 1993 Jun; 150(11):5013-24. PubMed ID: 8496602 [TBL] [Abstract][Full Text] [Related]
10. The mouse BP-1 gene: structure, chromosomal localization, and regulation of expression by type I interferons and interleukin-7. Wang J; Walker H; Lin Q; Jenkins N; Copeland NG; Watanabe T; Burrows PD; Cooper MD Genomics; 1996 Apr; 33(2):167-76. PubMed ID: 8660964 [TBL] [Abstract][Full Text] [Related]
11. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells. Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031 [TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter. Bräuninger A; Strebhardt K; Rübsamen-Waigmann H Oncogene; 1995 Nov; 11(9):1793-800. PubMed ID: 7478607 [TBL] [Abstract][Full Text] [Related]
13. PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter. Ying H; Chang JF; Parnes JR J Immunol; 1998 Mar; 160(5):2287-96. PubMed ID: 9498769 [TBL] [Abstract][Full Text] [Related]
14. Comparative structure and evolution of murine CR2. The homolog of the human C3d/EBV receptor (CD21). Fingeroth JD J Immunol; 1990 May; 144(9):3458-67. PubMed ID: 2139457 [TBL] [Abstract][Full Text] [Related]
15. A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2. Molina H; Kinoshita T; Inoue K; Carel JC; Holers VM J Immunol; 1990 Nov; 145(9):2974-83. PubMed ID: 2145366 [TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a differentiation-dependent gene in the human colonic cell line HT29-18. Oliva MM; Wu TC; Yang VW Arch Biochem Biophys; 1993 Apr; 302(1):183-92. PubMed ID: 8470895 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the complement receptor 2 gene: role of a heterogeneous nuclear ribonucleoprotein. Tolnay M; Lambris JD; Tsokos GC J Immunol; 1997 Dec; 159(11):5492-501. PubMed ID: 9548489 [TBL] [Abstract][Full Text] [Related]
18. Cloning, sequencing, and functional analysis of the 5'-flanking region of the rat 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase gene. Lin HK; Penning TM Cancer Res; 1995 Sep; 55(18):4105-13. PubMed ID: 7664287 [TBL] [Abstract][Full Text] [Related]
19. Expression of the murine CD21 gene is regulated by promoter and intronic sequences. Hu H; Martin BK; Weis JJ; Weis JH J Immunol; 1997 May; 158(10):4758-68. PubMed ID: 9144490 [TBL] [Abstract][Full Text] [Related]
20. Variability of CR2 gene products is due to alternative exon usage and different CR2 alleles. Toothaker LE; Henjes AJ; Weis JJ J Immunol; 1989 May; 142(10):3668-75. PubMed ID: 2565927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]